Pfeiffer Vacuum apprentices win award for virtual training film
Avoids translation misunderstandings as pumps firm expands into Asia
Alena Bölzer, Meike König, Oxana Pozdeev and Lisa Weichl won the ‘Unique products and services’ category for their virtual training films, which explain the steps involved in handling individual turbo pumps and other Pfeiffer Vacuum products. The films are practically speech-free so that any misunderstandings in language translation are avoided.
‘We are proud of our young employees,’ said Matthias Wierner, executive board member responsible for marketing, production and development at Pfeiffer Vacuum Technology. ‘They have not only had a great idea and implemented it well but have also presented their results professionally. Pfeiffer Vacuum will this year become even more international with a clear orientation towards Asia. We are very pleased that this situation is being addressed constructively and innovatively by all our staff.’
The company recently set up a subsidiary in São Paulo, Brazil and now has its own subsidiaries in Brazil, Russia, India and China.
Pfeiffer Vacuum reported unaudited sales of €220.5m in 2010, an increase of 21%.
You may also like
Finance
ScaleReady awards nearly $2m in G-Rex grants to advance cell and gene therapy manufacturing in California
The initiative supports leading academic GMP facilities in developing scalable, cost-effective platforms for CAR-T and other cell therapies, reinforcing California’s position as a global hub for CGT innovation
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Micro Spargers improve Bioreactor yields
Biotech Fluidics has launched a range of micro spargers engineered to significantly reduce bubble size and increase gas transfer and volumetric mass transfer coefficient (kLa), resulting in reduced gas consumption and improved upstream reactor yields
Manufacturing
Kindeva launches new UK HQ and manufacturing hub to develop eco-friendly inhaler propellants
The new Loughborough facility will support drug development from early-stage analysis to commercialisation, helping the industry transition to low-GWP inhaler solutions whilst strengthening Kindeva’s global footprint